Capital Income Builder - Class R-5E (RIRHX)

The Capital Income Builder - Class R-5E (RIRHX) is a mutual fund that focuses on generating income and long-term capital growth for its investors. It invests in a diverse portfolio of stocks, bonds, and other securities, with a focus on high-quality, dividend-paying companies. This fund is designed for investors seeking a balanced approach to income and growth, with a lower expense ratio compared to other classes of the same fund. Its ticker symbol is RIRHX.

RIRHX Mutual Fund Chart & Stats

$84.25

At close: Nov 04 4:00 PM EST

Previous Close: $84.25
Sub-Category: Asset Allocation
Total Liabilities: $2.85B
Expense Ratio: 0.41%
Holding Count: 2,766
Brand: Capital Income Builder
Category: Balanced
Total Assets: 133.31B
Shares Outstanding: N/A
52-Week Range: $76.02 - $84.93

RIRHX Mutual Fund News

AI Daily: Infrastructure faces new hurdles after election upheaval

Catch up on the top artificial intelligence news and commentary by Wall Street analysts on publicly traded companies in the space with this daily recap compiled by The Fly. DATA

1h agoBX AMD

OpenAI’s Brockman announces strategic partnership with JPMorgan

Greg Brockam, President & Co-Founder of OpenAI, said via X that, “Announcing our strategic partnership with JPMorgan (JPM)Chase, to explore how advanced AI can support their enterprise: helping engineers build,

2h agoJPM CMC

Private Markets: Shield AI, Kalshi lead week’s biggest moves

Two of the private market’s most closely watched unicorns made headlines this week, as Shield AI unveiled plans for a multibillion-dollar acquisition and Kalshi boosted its valuation to $40B following

2h agoBA BX

Bearish options flow identified in Broadcom with shares down 8.47%

Bearish options flow identified in Broadcom (AVGO), with shares down $27.57 near $297.90. Options volume running well above average with 418k contracts traded and puts leading calls for a put/call

2h agoAVGO 1YD

Bearish options flow identified in Broadcom with shares down 8.47%

Bearish options flow identified in Broadcom (AVGO), with shares down $27.57 near $297.90. Options volume running well above average with 418k contracts traded and puts leading calls for a put/call

2h agoAVGO 1YD

JPMorgan Chase Stock (JPM) Falls on Reports Democrats Plan to Probe Its Ties to Jeffrey Epstein

The bank has said it regrets its past association with the financier.

3h agoJPM MSFT

AbbVie Advances New Facial-Line Injection Study as Investors Watch Aesthetic Growth

Abbvie ($ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie is studying a new injectable combination for moderate to severe upper facial lines. The official title is

4h agoABBV

AbbVie Updates Early-Stage Drug Interaction Study: What ABBV Investors Should Know

Abbvie ($ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie’s NCT07649954 trial, titled “A Phase 1 Open-Label, Two-Period Study to Evaluate the Impact of Multiple Doses of

4h agoABBV

Shield AI to hit $28.8B value with $5.3B radar acquisition, Bloomberg says

Shield AI is buying a radar company for $5.3B, and raising $2.5B in new funding for it, the company plans to announce on Thursday, Bloomberg’s Rebecca Torrence reports. The new

5h agoBX JPM

Drone Delivery Group Zipline Now Valued at $21.5B as It Expands Walmart (WMT) Grocery Deal

Drone delivery firm Zipline has raised $1.5 billion to build a U.S.-wide network including ramping up an existing deal with retail giant Walmart ($WMT). Zipline said the cash-raise now valued

7h agoCRM JPM

Regulatory Risks Loom Large for JPMorgan Chase: How Evolving Oversight Could Constrain Growth and Profitability

JPMorgan Chase & Co. (JPM) has disclosed a new risk, in the Regulation category. Supervision and regulation remains a significant external risk for JPMorgan Chase & Co., as evolving rules

15h agoJPM CMC

AstraZeneca recently made $10B offer to buy Rhythm Pharmaceuticals, WSJ says

AstraZeneca (AZN) recently made a roughly $10B offer to acquire Rhythm Pharmaceuticals (RYTM) for $124 per share, according to people familiar with the matter, The Wall Street Journal’s Lauren Thomas

1d agoAZN RYTM

Qualcomm (QCOM) Signs Multi-Year Deal to Supply 5G Network Gear for SpaceX’s Starlink Mobile

Qualcomm ($QCOM) signed a multi-year agreement on Wednesday to provide 5G cell tower hardware and software for SpaceX’s ($SPCX) upcoming Starlink Mobile wireless network across the United States. QCOM shares

1d agoAVGO INTC

AstraZeneca Builds Hong Kong Breast Cancer Evidence in New Real-World Study

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s official study title is Breast Cancer Real-World Insights and Decision Guidance Evaluation (BRIDGE-HK) An Observational, Retrospective,

1d agoAZN

Top 10 Holdings

The fund's ten largest positions
Name	Weight %
USD_CASHCAPITAL GROUP CENTRAL CASH FUND	4.22%
AVGOBroadcom Inc.	4.02%
2330TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD	3.38%
PMPhilip Morris International	2.94%
CCBFXCAPITAL GROUP CENTRAL CORPORATE BOND FUND	2.04%
ABBVAbbvie	1.93%
BATSBritish American Tobacco (UK)	1.85%
RTXRtx Corporation	1.57%
JPMJPMorgan Chase & Co.	1.17%
AZNAstraZeneca plc	1.10%
Total	24.21%

Go to Holdings >

Capital Income Builder - Class R-5E (RIRHX)

RIRHX Mutual Fund Chart & Stats

RIRHX Mutual Fund News

AI Daily: Infrastructure faces new hurdles after election upheaval

OpenAI’s Brockman announces strategic partnership with JPMorgan

Private Markets: Shield AI, Kalshi lead week’s biggest moves

Bearish options flow identified in Broadcom with shares down 8.47%

Bearish options flow identified in Broadcom with shares down 8.47%

JPMorgan Chase Stock (JPM) Falls on Reports Democrats Plan to Probe Its Ties to Jeffrey Epstein

AbbVie Advances New Facial-Line Injection Study as Investors Watch Aesthetic Growth

AbbVie Updates Early-Stage Drug Interaction Study: What ABBV Investors Should Know

Shield AI to hit $28.8B value with $5.3B radar acquisition, Bloomberg says

Drone Delivery Group Zipline Now Valued at $21.5B as It Expands Walmart (WMT) Grocery Deal

Regulatory Risks Loom Large for JPMorgan Chase: How Evolving Oversight Could Constrain Growth and Profitability

AstraZeneca recently made $10B offer to buy Rhythm Pharmaceuticals, WSJ says

Qualcomm (QCOM) Signs Multi-Year Deal to Supply 5G Network Gear for SpaceX’s Starlink Mobile

AstraZeneca Builds Hong Kong Breast Cancer Evidence in New Real-World Study

Top 10 Holdings

Recently Viewed

Become an Expert with TipRanks Premium